tiprankstipranks
Cingulate reports Q3 net loss $3.2M vs. $5.98M last year
PremiumThe FlyCingulate reports Q3 net loss $3.2M vs. $5.98M last year
2M ago
Cingulate sees cash runway into 3Q25
Premium
The Fly
Cingulate sees cash runway into 3Q25
2M ago
Cingulate files to sell 1.5M shares of common stock for holders
Premium
The Fly
Cingulate files to sell 1.5M shares of common stock for holders
3M ago
Cingulate files to sell 1M shares of common stock for holders
PremiumThe FlyCingulate files to sell 1M shares of common stock for holders
5M ago
Cingulate issued European patent for CTx-1301 for ADHD
Premium
The Fly
Cingulate issued European patent for CTx-1301 for ADHD
5M ago
Cingulate sees cash runway late into 3Q24
Premium
The Fly
Cingulate sees cash runway late into 3Q24
5M ago
Cingulate Inc. Stockholders Bolster Governance and Growth Strategy
PremiumCompany AnnouncementsCingulate Inc. Stockholders Bolster Governance and Growth Strategy
7M ago
Cingulate receives confirmation from FDA on NDA for CTx-1301
Premium
The Fly
Cingulate receives confirmation from FDA on NDA for CTx-1301
8M ago
Cingulate files to sell 2M shares of common stock for holders
Premium
The Fly
Cingulate files to sell 2M shares of common stock for holders
8M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100